Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis

Journal of Experimental Medicine

Volumn 202, Issue 2, 2005, Pages 249-259

  Miyaji, Michihiko ^a,b   Jin, Zhe Xiong ^a,c   Yamaoka, Shohei ^d   Amakawa, Ryuichi ^b   Fukuhara, Shirou ^b   Sato, Satoshi B ^a,e   Kobayashi, Toshihide ^e   Domae, Naochika ^f   Mimori, Tsuneyo ^a   Bloom, Eda T ^g   Okazaki, Toshiro ^d   Umehara, Hisanori ^a,c  

^a KYOTO UNIVERSITY   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

^d TOTTORI UNIVERSITY   (Japan)

^e RIKEN   (Japan)

^f OSAKA DENTAL UNIVERSITY   (Japan)

^g CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CERAMIDE; FAS ANTIGEN; MEMBRANE PROTEIN; MEMBRANE RECEPTOR; SPHINGOMYELIN;

APOPTOSIS; ARTICLE; ENZYME ACTIVATION; GENE; GENE CLUSTER; GENE FUNCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIPID RAFT; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CASPASES; CELL LINE, TUMOR; CERAMIDES; GENE DELETION; HUMANS; MEMBRANE MICRODOMAINS; MICE; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SPHINGOMYELINS; TRANSFECTION; TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS);

EID: 22944475327     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20041685     Document Type: Article

References (57)

1. Marsden, V.S., and A. Strasser. 2003. Control of apoptosis in the immune system: Bcl-2, BH-3 only proteins and more. Annu. Rev. Immunol. 21:71-105.
2. Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K.J. Tomaselli, K.M. Debatin, P.H. Krammer, and M.E. Peter. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1675-1687.
3. Wajant, H. 2002. The Fas signaling pathway: more than a paradigm. Science. 296:1635-1636.
4. Hengartner, M.O. 2000. The biochemistry of apoptosis. Nature. 407: 770-776.
5. Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature. 387:569-572.
6. Brown, D.A., and E. London. 1998. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14:111-136.
7. Grassme, H., A. Jekle, A. Riehle, H. Schwarz, J. Berger, K. Sandhoff, R. Kolesnick, and E. Gulbins. 2001. CD95 signaling via ceramide-rich membrane rafts. J. Biol. Chem. 276:20589-20596.
8. Inoue, H., O. Yoneda, Y. Minami, Y. Tanaka, T. Okazaki, H. Imai, E. Bloom, N. Domae, and H. Umehara. 2002. Lipid rafts as the signaling scaffold for NK cell activation: tyrosine phosphorylation and association of LAT with PI 3-kinase and PLC-γ following CD2 stimulation. Eur. J. Immunol. 32:2188-2198.
9. Delmas, D., C. Rebe, S. Lacour, R. Filomenko, A. Athias, P. Gambert, M. Cherkaoui-Malki, B. Jannin, L. Dubrez-Daloz, N. Latruffe, and E. Solary. 2003. Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells. J. Biol. Chem. 278:41482-41490.
10. Cremesti, A., F. Paris, H. Grassme, N. Holler, J. Tschopp, Z. Fuks, E. Gulbins, and R. Kolesnick. 2001. Ceramide enables Fas to cap and kill. J. Biol. Chem. 276:23954-23961.
11. Grassme, H., A. Cremesti, R. Kolesnick, and E. Gulbins. 2003. Ceramide-mediated clustering is required for CD95-DISC formation. Oncogene. 22:5457-5470.
12. Yamaoka, S., M. Miyaji, T. Kitano, H. Umehara, and T. Okazaki. 2004. Expression cloning of a human cDNA restoring sphingomyelin synthesis and cell growth in sphingomyelin synthase-deficient cells. J. Biol. Chem. 279:18688-18693.
13. Huitema, K., J.V.D. Dikkenberg, J.F. Brouwers, and J.C. Holhuis. 2004. Identification of a family of animal sphingomyelin synthases. EMBO J. 23:33-44.
14. Yamaji, A., Y. Sekizawa, K. Emoto, H. Sakuraba, K. Inoue, H. Kobayashi, and M. Umeda. 1998. Lysenin, a novel sphingomyelin-specific binding protein. J. Biol. Chem. 273:5300-5306.
15. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66:233-243.
16. Yamaji-Hasegawa, A., A. Makino, T. Baba, Y. Senoh, H. Kimura-Suda, S.B. Sato, N. Terada, S. Ohno, E. Kiyokawa, M. Umeda, and T. Kobayashi. 2003. Oligomerization and pore formation of a sphingomyelin-specific toxin, lysenin. J. Biol. Chem. 278:22762-22770.
17. Sato, S.B., K. Ishii, A. Makino, K. Iwabuchi, A. Yamaji-Hasegawa, Y. Senoh, I. Nagaosa, H. Sakuraba, and T. Kobayashi. 2004. Distribution and transport of cholesterol-rich membrane domains monitored by a membrane-impermeant fluorescent polyethylene glycol-derivatized cholesterol. J. Biol. Chem. 279:23790-23796.
18. Mundle, S.D., and A. Raza. 2002. Defining the dynamics of selfassembled Fas-receptor activation. Trends Immunol. 23:187-194.
19. Siegel, R.M., J.K. Frederiksen, D.A. Zacharias, F.K.M. Chan, M. Johnson, D. Lynch, R.Y. Tsien, and M. Lenardo. 2000. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science. 288:2354-2357.
20. Chan, F.K.M., H.J. Chun, L. Zheng, R.M. Siegel, K.L. Bui, and M.J. Lenardo. 2000. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science. 288:2351-2354.
21. Golstein, P. 2000. FasL binds preassembled Fas. Science. 288:2328-2329.
22. Kamitani, T., H.P. Nguyen, and E.T.H. Yeh. 1997. Activationinduced aggregation and processing of the human Fas antigen. J. Biol. Chem. 272:22307-22314.
23. Lee, Y.-J., and E. Shacter. 2001. Fas aggregation does not correlate with Fas-mediated apoptosis. J. Immunol. 167:82-89.
24. Dykstra, M., A. Cherukuri, H.W. Sohn, S.J. Tzeng, and S.K. Pierce. 2003. Location is everything: lipid rafts and immune cell signaling. Annu. Rev. Immunol. 21:457-481.
25. Muppidi, J., and R.M. Siegel. 2004. Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic death. Nat. Immunol. 5:182-189.
26. Kondo, T., K. Iwai, T. Kitano, M. Watanabe, Y. Taguchi, T. Yabu, H. Umehara, N. Domae, T. Uchiyama, and T. Okazaki. 2002. Control of ceramide-induced apoptosis by IGF-1: involvement of PI-3 kinase, caspase-3 and catalase. Cell Death Differ. 9:682-692.
27. Iwai, K., T. Kondo, M. Watanabe, T. Yabu, Y. Taguchi, H. Umehara, A. Takahashi, T. Uchiyama, and T. Okazaki. 2003. Ceramide increases oxidative damage due to inhibition of catalase by caspase-3-dependent proteolysis in HL-60 cell apoptosis. J. Biol. Chem. 278:9813-9822.
28. Watanabe, I., T. Kitano, T. Kondo, T. Yabu, Y. Taguchi, M. Tashima, H. Umehara, N. Domae, T. Uchiyama, and T. Okazaki. 2004. Increase of nuclear ceramide through caspase-3-dependent regulation of the "sphingomyelin (SM) cycle" in Fas-induced apoptosis. Cancer Res. 64:1000-1007.
29. Tepper, A.D., P. Ruurs, T. Wiedmer, P.J. Sims, J. Borst, and W.J. van Blitterswijk. 2000. Sphingomyelin hydrolysis to ceramide during the execution phase of apoptosis results from phospholipid scrambling and alters cell-surface morphology. J. Cell Biol. 150:155-164.
30. Hetz, C.A., M. Hunn, P. Rojas, V. Torres, L. Leyton, and A.F.G. Quest. 2002. Caspase-dependent initiation of apoptosis and necrosis by the Fas receptor in lymphoid cells: onset of necrosis is associated with delayed ceramide increase. J. Cell Sci. 115:4671-4683.
31. Blitterswijk, W.J.V., A.H. van der Luit, R.J. Veldman, and J. Borst. 2003. Ceramide: second messenger or modulator of membrane structure and dynamics? Biochem. J. 369:199-211.
32. Gulbins, E., and H. Grassme. 2002. Ceramide and cell death receptor clustering. Biochim. Biophys. Acta. 1585:139-145.
33. Kolesnick, R., and Z. Fuks. 2003. Radiation and ceramide-induced apoptosis. Oncogene. 22:5897-5906.
34. Pettus, B.J., C.E. Chalfant, and Y.A. Hannum. 2002. Ceramide in apoptosis: an overview and current perspective. Biochim. Biophys. Acta. 1585:114-125.
35. Sawai, H., T. Okazaki, Y. Takeda, M. Tashima, H. Sawada, M. Okuma, S. Kishi, H. Umehara, and N. Domae. 1997. Ceramideinduced translocation of protein kinase C-delta and -epsilon to the cytosol. J. Biol. Chem. 272:2452-2458.
36. Kondo, T., Y. Suzuki, T. Kitano, K. Iwai, M. Watanabe, H. Umehara, N. Daido, N. Domae, M. Tashima, T. Uchiyama, and T. Okazaki. 2002. Vesnarinone causes oxidative damage by inhibiting catalase function through ceramide action in myeloid cell apoptosis. Mol. Pharmacol. 61:620-627.
37. Uchida, Y., M. Itoh, Y. Taguchi, S. Yamaoka, M. Umeda, S. Ichikawa, Y. Hirabayashi, W.M. Holleran, and T. Okazaki. 2004. Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through Doxorubicin-activated Sp1 in drug-resistant HL-60/ADR cells. Cancer Res. 64:6271-6279.
38. -/- hepatocytes. J. Biol. Chem. 276:8297-8305.
39. Schneider, P., N. Holler, J.-L. Bodmer, M. Hahne, K. Frei, A. Fontana, and J. Tschopp. 1998. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with down-regulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187: 1205-1213.
40. Huang, D.C.S., M. Hahne, M. Schroeter, K. Frei, A. Fontana, A. Villunger, K. Newton, J. Tschopp, and A. Strasser. 1999. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-XL. Proc. Natl. Acad. Sci. USA. 96:14871-14876.
41. Papoff, G., P. Hausler, A. Eramo, M.G. Pagano, G.D. Leve, A. Signore, and G. Ruberti. 1999. Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor. J. Biol. Chem. 274:38241-38250.
42. Gulbins, E., and R. Kolesnick. 2003. Raft ceramide in molecular medicine. Oncogene. 22:7070-7077.
43. Cherukuri, A., M. Dykstra, and S.K. Pierce. 2001. Floating the raft hypothesis: Lipid rafts play a role in immune cell activation. Immunity. 14: 657-660.
44. Bromley, S.K., W.R. Burack, K.G. Johnson, K. Somersalo, T.N. Sims, C. Sumen, M.M. Davis, A.S. Shaw, P.M. Allen, and M.L. Dustin. 2001. The immunological synapse. Annu. Rev. Immunol. 19:375-396.
45. Davis, D.M. 2002. Assembly of the immunological synapse for T cell and NK cells. Trends Immunol. 23:356-363.
46. London, M., and L. Erwin. 2004. Ceramide selectively displaces cholesterol from ordered lipid domain (Rafts). J. Biol. Chem. 279:9997-10004.
47. Veiga, M.P., J.L.R. Arrondo, F.M. Goni, and A. Alonso. 1999. Ceramides in phospholipid membranes: effects on bilayer stability and transition to nonlamellar phases. Biophys. J. 76:342-350.
48. Holopainen, J.M., M. Subramanian, and P.K. Kinnunen. 1998. Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/ sphingomyelin membrane. Biochemistry. 37:17562-17570.
49. Grassme, H., V. Jendrossek, A. Riehle, G. von Kurthy, J. Berger, H. Schwarz, M. Weller, R. Kolesnick, and E. Gulbins. 2003. Host defence against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat. Med. 9:322-330.
50. Okazaki, T., R.M. Bell, and Y.A. Hannun. 1989. Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. J. Biol. Chem. 264: 19076-19080.
51. Liu, P., and R.G. Anderson. 1995. Compartmentalized production of ceramide at the cell surface. J. Biol. Chem. 270:27179-27185.
52. Algeciras-Schimnich, A., L. Shen, B.C. Barnhart, A.E. Murmann, J.K. Burkhardt, and M.E. Peter. 2002. Molecular ordering of the initial signaling events of CD95. Mol. Cell. Biol. 22:207-220.
53. Bligh, E., and W. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
54. syk and phosphatidylinositol 3-kinase in CD2-mediated granular exocytosis in natural killer cell line. J. Immunol. 159:1200-1207.
55. syk, resulting in increased tyrosine phosphorylation of adapter proteins, Shc and Cbl. Int. Immunol. 10:833-845.
56. lck associated with glycolipid-enriched membrane domains. J. Cell Biol. 135:1515-1523.
57. Okazaki, T., A. Bielawska, R.M. Bell, and Y.A. Hannun. 1990. Role of ceramide as a lipid mediator of 1 alpha, 25-dehydroxyvitamin D3-induced HL-60 cell differentiation. J. Biol. Chem. 265:15823-15831.